AMGEN T-VEC_Atezolizumab The goal of this study is to evaluate the safety of intrahepatic injection (directly into the liver) of talimogene laherparepvec in combination with intravenously administered atezolizumab in subjects with triple negative breast cancer and colorectal cancer with liver metastases. (Aktiv)
Erstlinie
PREPARE Prevention of paclitaxel-related neurological side effects with lithium carbonate – a randomized, double-blind, placebo-controlled, explorative proof-of-concept phase II clinical trial to counteract chemotherapy induced neurotoxicity (PREPARE trial) (Aktiv)